262 results match your criteria: "Division of Clinical Infectious Diseases[Affiliation]"
Yakugaku Zasshi
September 2020
Division of Clinical Infectious Diseases and Chemotherapy, Graduate School of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University.
In medical care, qualified physicians, nurses, and pharmacists have come to be recognized as a team integral to a patient's success, and this team approach to medical care has become popular. In the infectious disease field, more hospitals are practicing antimicrobial stewardship as a team, in addition to the conventional infection control team (ICT). As a result, infectious disease chemotherapy pharmacists are in demand.
View Article and Find Full Text PDFSci Rep
February 2020
Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road MS F08, Atlanta, GA, 30329, USA.
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
View Article and Find Full Text PDFIntern Med
May 2020
Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan.
A 72-year-old woman was admitted to our hospital with bilateral pleural effusions. She had a 31-year history of systemic lupus erythematosus and had been treated with prednisolone and azathioprine. Pleural fluid culture revealed Salmonella enterica subsp.
View Article and Find Full Text PDFEnviron Health Prev Med
February 2020
Division of Clinical Infectious Diseases, Department of Infection and Immunity, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke, 329-0498, Japan.
Following publication of the original article [1], the authors spotted errors in their paper concerning the positive rate in the right side in Table 2.
View Article and Find Full Text PDFBMC Infect Dis
January 2020
Microbiology and Morphology Laboratory, Institute of Phthisiopneumology, Chisnau, Moldova.
Background: Recurrence of drug-resistant tuberculosis (DR-TB) after treatment occurs through relapse of the initial infection or reinfection by a new drug-resistant strain. Outbreaks of DR-TB in high burden regions present unique challenges in determining recurrence status for effective disease management and treatment. In the Republic of Moldova the burden of DR-TB is exceptionally high, with many cases presenting as recurrent.
View Article and Find Full Text PDFIndian Pediatr
December 2019
Division of Clinical Infectious Diseases, Department of Pediatric Infectious Diseases, B J Wadia Hospital for Children, Mumbai, India.
Environ Health Prev Med
December 2019
Division of Clinical Infectious Diseases, Department of Infection and Immunity, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke, 329-0498, Japan.
Background: Two types of recombinant hepatitis B virus (HBV) vaccines are available in Japan. One type uses the antigen from genotype A (Heptavax-II®) and the other uses the antigen from genotype C (Bimmugen®). Potential differences in productivity of the hepatitis B virus surface (HBs) antibody between vaccines have not been studied in detail.
View Article and Find Full Text PDFInt J Clin Pharm
December 2019
Department of Pharmacy, Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Background De-escalation therapy is recommended as an effective antibiotic treatment strategy for several infectious diseases. While there is limited evidence supporting its clinical and cost-effective outcomes in patients with community-acquired bacteremic pneumonia, there is no evidence in patients with nonbacteremic pneumonia. Objective This study aimed to evaluate the antibiotic costs in patients who did and did not receive de-escalation therapy, based on the 2017 Japanese guidelines for the management of community-acquired nonbacteremic pneumococcal pneumonia of the Japanese Respiratory Society (JRS).
View Article and Find Full Text PDFInfection
December 2019
Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Purpose: This study aimed to evaluate the efficacy of an educational intervention on reducing the inappropriate use of oral third-generation cephalosporins, the prevalence of resistant bacteria, and clinical outcomes.
Methods: A before-after study was conducted to compare the data for 1 year before and after intervention at a Japanese university hospital. Educational intervention included lectures for all medical staff on oral antibiotics and educational meetings with each medical department.
J Infect Chemother
February 2020
Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) is associated with poor clinical outcomes. We surveyed clinical outcomes of MRSA pneumonia in daily practice to identify risk factors for the clinical failure and mortality in patients with MRSA pneumonia. This multicenter prospective observational study was performed across 48 Japanese medical institutions.
View Article and Find Full Text PDFInt J Tuberc Lung Dis
August 2019
Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, German Center for Infection Research, Clinical Tuberculosis Center, Borstel, Respiratory Medicine/International Health, University of Lübeck, Lübeck, Germany.
IDCases
August 2019
Division of Clinical Infectious Diseases, Department of Infection and Immunity, School of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, Japan.
J Infect Chemother
September 2019
The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan.
PLoS One
February 2020
Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Background: The incidence of ocular candidiasis (OC) in patients with candidemia varies across different reports, and the issue of whether routine ophthalmoscopy improves outcomes has been raised. This study investigated the incidence of OC and evaluate whether the extent of OC impacts the clinical outcomes.
Methods: This retrospective study included non-neutropenic patients with candidemia who underwent treatment at one of 15 medical centers between 2010 and 2016.
Int J Tuberc Lung Dis
April 2019
Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany, German Center for Infection Research (DZIF), Braunschweig, Germany, International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany, Department of Medicine, Karolinska Institute, Stockholm, Sweden, Email:
Clin Infect Dis
February 2020
Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences.
Background: There are limited data for direct comparisons of the efficacy of oral itraconazole (ITCZ) and oral voriconazole (VRCZ) therapy in the treatment of chronic pulmonary aspergillosis (CPA).
Methods: We conducted a retrospective, follow-up, observational study of CPA patients enrolled in 2 previous multicenter trials.
Results: Of the 273 CPA patients, 59 and 101 patients started maintenance therapy with oral ITCZ and oral VRCZ, respectively, just after the end of acute intravenous therapy in each trial.
Int J Tuberc Lung Dis
January 2019
Division of Clinical Infectious Diseases, Research Centre Borstel, Borstel, German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel, International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide. Active cigarette smoking may have a significant impact on treatment responses to anti-tuberculosis treatment.
Objective: To ascertain the effect of smoking on sputum culture conversion rates following treatment initiation in patients with susceptible, multidrug-resistant and extensively drug-resistant TB (M/XDR-TB).
Neurocrit Care
August 2019
Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy.
Background: There are currently few data concerning the cerebrospinal fluid (CSF) penetration of daptomycin in patients with healthcare-associated meningitis. This study aims (1) to better characterize the pharmacokinetics of daptomycin in humans during a 7-day intravenous (IV) therapy course, and (2) to study the penetration of daptomycin in the CSF after IV infusion at the dose of 10 mg/kg.
Results: In this prospective observational study, we enrolled nine patients with an implanted external ventricular drainage and a diagnosis of a healthcare-associated meningitis.
J Infect Chemother
February 2019
The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Division of Clinical Infectious Diseases, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan.
Sci Rep
October 2018
Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road MS F08, Atlanta, GA, 30329, USA.
Drug-resistant tuberculosis poses a persistent public health threat. The ReSeqTB platform is a collaborative, curated knowledgebase, designed to standardize and aggregate global Mycobacterium tuberculosis complex (MTBC) variant data from whole genome sequencing (WGS) with phenotypic drug susceptibility testing (DST) and clinical data. We developed a unified analysis variant pipeline (UVP) ( https://github.
View Article and Find Full Text PDFFront Microbiol
October 2018
German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel, Borstel, Germany.
Lancet
September 2018
Montreal Chest Institute, McGill University Health Center Research Institute, McGill University, Montreal, QC, Canada. Electronic address:
Background: Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration of treatment with those drugs in patients with multidrug-resistant tuberculosis.
Methods: In this individual patient data meta-analysis, we searched MEDLINE, Embase, and the Cochrane Library to identify potentially eligible observational and experimental studies published between Jan 1, 2009, and April 30, 2016.
Am J Infect Control
December 2018
Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, Tokyo, Japan.
Background: Few published data are available on the morbidity and mortality of bloodstream infections (BSIs) in Japan. We sought to investigate the epidemiology of BSIs, the involvement of antimicrobial resistance, and the factors that influence patient prognosis.
Methods: This single-center study retrospectively evaluated patients who were found to have positive blood cultures at a tertiary teaching hospital between January 2012 and December 2016.
J Infect Chemother
November 2018
Division of Infectious Disease and Hospital Epidemiology, Saga University Hospital, Saga, Japan; Division of Clinical Infectious Diseases, Department of International Medicine, Faculty of Medicine, Saga University, Japan.
Objective: To study how and to what degree the rapid pathogen identification by MALDI-TOF MS coupled with rapid disk diffusion test improve the current clinical practice of patients with bacteremia in a tertiary teaching hospital with full-time ID consultation service.
Patients And Methods: MALDI-TOF MS and 8H disk diffusion tests were directly applied to the positive blood cultures samples and the results were reflected on antimicrobial therapy (n = 119). The appropriateness of antimicrobial selection through these interventions was verified with conventional culture results in comparison with historical control (n = 129).
Front Immunol
July 2018
Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
Background: In order to eliminate tuberculosis (TB), an effective vaccine is urgently needed to prevent infection with . A key obstacle for the development of novel TB vaccines is the lack of surrogate markers for immune protection against .
Methods: We investigated growth rates of in the mycobacterial growth inhibition assay (MGIA) as a marker for mycobacterial growth control of human bronchoalveolar lavage (BALC) and peripheral blood mononuclear cells (PBMC) before and after vaccination with Bacille Calmette-Guérin (BCG) of healthy adult volunteers.